A Pilot Study of Single Pegfilgrastim Compared with Intermittent Every Other Days of 5 Shot-Filgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) Chemotherapy (G-CSF 105 Trial: NCT02685111)

Annals of oncology(2018)

引用 0|浏览58
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要